Venue suggestions

Venue Recommendations

as_is

None. The editor's verdict is major revision, and the two quantitative claims that anchor the Abstract are not supported as stated. Submission to a peer-reviewed venue without addressing the statistical and confounding issues would be premature.

---

after_revision

Nature Methods

• Fit: This is the natural home for a methodological framework that combines two established techniques (patch-clamp + mass spectrometry) and explicitly addresses a practical bottleneck (soma retrieval variability) that the existing patch-SCP literature has under-recognised. The paper's emphasis on honest benchmarking, negative results, and compartmental limitations aligns with Nature Methods' editorial preference for methods papers that acknowledge constraints rather than oversell capability. The data deposition (PXD068359, videos, code) and transparent reporting already meet the venue's reproducibility standards.
• Odds: Moderate (50–60%). After revision, the paper will have a solid empirical foundation (the capacitance observation in n=3 reported descriptively, the size confound resolved, the shotgun strategy validated). The framework contribution is genuine and under-published. However, Nature Methods typically expects either broader scope (more neurons, more brain regions) or deeper mechanistic insight (e.g., linking specific ion channels to spike properties). The authors' honest acknowledgement that n=12 is exploratory and that distal proteins are under-sampled will help, but a reviewer may still ask whether the work is ready for a flagship methods venue or whether it belongs in a more specialist outlet first.

eLife

• Fit: eLife explicitly values methodological contributions that are honest about limitations and that advance a field by clarifying what can and cannot be done. The paper's framework, the decision to analyse all retrievals, and the candid Discussion about compartmental bias and incomplete channel recovery are exactly what eLife rewards. The work is positioned as exploratory and preliminary, which eLife accepts when the claims are scaled appropriately. The ethics and data-sharing record is exemplary.
• Odds: Moderate–good (55–65%). eLife has published patch-seq and single-cell proteomics methods papers before, and this one offers a genuinely useful reframing of the retrieval problem. The required revisions are textual and analytical, not experimental. The main risk is that after revision, the paper's scope may still feel narrow (n=12, one brain region, one cell type) for a broad-audience venue. However, eLife's handling of exploratory work is more generous than Nature Methods', and the framework's applicability to future patch-SCP studies across systems is clear.

Molecular Systems Biology

• Fit: MSB publishes systems-level proteomics and integrative methods papers. While this manuscript is not a full systems analysis, it makes a methodological contribution to linking electrophysiology and proteomics at the single-cell level, which is squarely in MSB's scope. The paper's emphasis on how retrieval mechanics shape what can be inferred from proteomes is a systems-level insight. MSB also has a strong track record of accepting exploratory, well-executed work with honest limitations.
• Odds: Moderate (50–55%). MSB may view the work as more of a technical methods paper than a systems contribution, which could be a fit issue. However, the paper's framing of how compartmental sampling and retrieval variability propagate into proteome interpretation is genuinely systems-level thinking. After revision, this is a plausible home, particularly if the authors emphasise the framework's applicability to future multi-region, multi-subtype studies.

---

alternative

Journal of Neuroscience Methods

• Fit: This is a specialist venue for methodological work in neuroscience, with a strong track record of publishing patch-clamp and single-cell profiling methods. The paper's framework, the shotgun strategy, and the honest assessment of retrieval variability are exactly what JNM publishes. The venue is less prestigious than Nature Methods or eLife, but it is highly read by the patch-clamp and patch-seq communities, and it has a faster review cycle.
• Odds: Good–very good (70–80%). After revision, this is a realistic and appropriate home. JNM does not demand the breadth or impact that Nature Methods does, and it explicitly welcomes exploratory work with clear limitations. The paper will reach the right audience here, and the framework will be cited by future patch-SCP studies. This is a strong fallback if the flagship venues decline.

Analytical Chemistry (or ACS Analytical Chemistry)

• Fit: The paper is fundamentally about mass spectrometry-based single-cell analysis and how to interpret proteomic recovery in the context of mechanical sampling constraints. Analytical Chemistry has published single-cell MS methods and applications, and the paper's focus on sample quality, retrieval variability, and proteome yield is analytically rigorous. The DIA-based workflow and the honest assessment of what the method can and cannot detect are analytically sound.
• Odds: Moderate (50–60%). Analytical Chemistry may view the work as more of a neuroscience application than a core analytical methods contribution, but the paper's emphasis on sample integrity, quantitative relationships between physical properties (capacitance) and analytical yield (protein identifications), and the limitations of hydrophobic protein recovery are all analytically interesting. This is a good alternative if the neuroscience-focused venues decline.

bioRxiv (preprint server, with invitation to submit to a journal after community feedback)

• Fit: The manuscript is already suitable for bioRxiv as a preprint. The editor's decision letter is constructive and specific, and the required revisions are feasible. Posting on bioRxiv with a note that revision is in progress would allow the community (especially patch-seq and patch-SCP researchers) to engage with the work and provide feedback before formal submission.
• Odds: Certain (100%, as a preprint). This is not a fallback but a practical next step: deposit the preprint on bioRxiv, revise according to the decision letter, and then submit to one of the peer-reviewed venues above. The public review process at In Silico (if the authors choose to pursue it) or the decision letter itself can be cited as evidence of community engagement.

---

Summary and Recommendation

Primary path: After revision, target eLife or Nature Methods in parallel. Both are realistic given the paper's quality and the specificity of the required fixes. eLife is slightly more likely to accept exploratory work with honest limitations; Nature Methods is more prestigious but may ask for broader scope.

Fallback path: Journal of Neuroscience Methods is a strong, realistic home that will reach the right audience and has a higher acceptance probability. This is not a consolation prize — it is a specialist venue where this work will be highly cited and influential.

Avoid: Do not submit to a general-audience venue (e.g., Nature Neuroscience, Neuron) without substantially expanding the dataset or the biological insight. The current n=12 and the exploratory framing, while honest, will not meet the bar for those journals.

Timeline: The required revisions are not experimental and should be completable in 4–6 weeks. The statistical and confounding issues are the critical path; once those are resolved, the paper is ready for submission.